Valsartan Sandoz 320 mg Norge - norsk - Statens legemiddelverk

valsartan sandoz 320 mg

sandoz - københavn - valsartan - tablett, filmdrasjert - 320 mg

Syvazul BTV Den europeiske union - norsk - EMA (European Medicines Agency)

syvazul btv

laboratorios syva, s.a.u. - inaktivert bluetongue virus, serotype 1, belastning alg2006/01 e1, inaktivert bluetongue virus, serotype 4, belastning btv-4/spa-1/2004, inaktivert bluetongue virus, serotype 8, belastning bel2006/01 - inaktivert viral vaksiner - cattle; sheep - for aktive vaksinering av sau for å hindre viraemia og redusere kliniske tegn og lesjoner forårsaket av bluetongue virus serotypes 1 og/eller 8 og/eller å redusere viraemia* og kliniske tegn og lesjoner forårsaket av bluetongue virus serotype 4for aktiv vaksinering av storfe for å hindre viraemia forårsaket av bluetongue virus serotypes 1 og/eller 8 og/eller å redusere viraemia* forårsaket av bluetongue virus serotype 4.

Metformin Sandoz 500 mg Norge - norsk - Statens legemiddelverk

metformin sandoz 500 mg

sandoz - københavn - metforminhydroklorid - tablett, filmdrasjert - 500 mg

Metformin Sandoz 1000 mg Norge - norsk - Statens legemiddelverk

metformin sandoz 1000 mg

sandoz - københavn - metforminhydroklorid - tablett, filmdrasjert - 1000 mg

Natriumfluorid (18 F) NMS 0.2 GBq/ ml Norge - norsk - Statens legemiddelverk

natriumfluorid (18 f) nms 0.2 gbq/ ml

norsk medisinsk syklotronsenter as - natriumfluorid (18f) - injeksjonsvæske, oppløsning - 0.2 gbq/ ml

Metformin Sandoz 850 mg Norge - norsk - Statens legemiddelverk

metformin sandoz 850 mg

sandoz - københavn - metforminhydroklorid - tablett, filmdrasjert - 850 mg

Optomease Vet 200 mg/ ml Norge - norsk - Statens legemiddelverk

optomease vet 200 mg/ ml

virbac s.a. - benzokain - konsentrat til behandlingsoppløsning til fisk - 200 mg/ ml

Spikevax (previously COVID-19 Vaccine Moderna) Den europeiske union - norsk - EMA (European Medicines Agency)

spikevax (previously covid-19 vaccine moderna)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaksiner - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Radiljos 250 MBq/ ml Norge - norsk - Statens legemiddelverk

radiljos 250 mbq/ ml

helse bergen hf, haukeland universitetssykehus - nukleærmedisin og pet - fludeoksyglukose (18f) - injeksjonsvæske, oppløsning - 250 mbq/ ml

Celsunax Den europeiske union - norsk - EMA (European Medicines Agency)

celsunax

pinax pharma gmbh - ioflupane (123i) - radionuclide imaging; dementia; movement disorders - diagnostiske radiopharmaceuticals - dette legemidlet er kun til diagnostisk bruk. celsunax is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum:in adult patients with clinically uncertain parkinsonian syndromes, for example those with early symptoms, in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic parkinson’s disease, multiple system atrophy and progressive supranuclear palsy.  celsunax is unable to discriminate between parkinson's disease, multiple system atrophy and progressive supranuclear palsy. hos voksne pasienter, for å kunne skille mellom sannsynlig demens med lewy legemer fra alzheimers sykdom.  celsunax is unable to discriminate between dementia with lewy bodies and parkinson’s disease dementia.